JWCA has advised Gilead Sciences on capital market transactions with over $20 billion in transaction value

September 2016: JWCA acts as Financial Advisor to Gilead Sciences on its $5.0 billion bond issuance

February 2016: JWCA advises Gilead Sciences on its $5.0 billion Accelerated Share Repurchase

September 2015: JWCA acts as Financial Advisor to Gilead Sciences on its $10.0 billion bond issuance